Science Explorer Back to mapMap
Discussion
Researcher · Abbott Fund · United States

Aaron R. Kunzer

Aaron R. Kunzer publishes mostly in Organic Chemistry, Molecular Biology and Radiology, Nuclear Medicine and Imaging, on topics such as Cell death mechanisms and regulation, Chemical Synthesis and Analysis and Asymmetric Synthesis and Catalysis.

OpenAlex
World rank
#1,079,341
of 7,710,434 ranked researchers
Rank in United States
#349,897
of 1,627,098
Works
28
Citations
4.8k
Citations per work
172.2
h-index
15
i10-index 15Top 37% in Organic Chemistry
Aaron R. Kunzer

What does Aaron R. Kunzer research?

Aaron R. Kunzer's work is mostly in Chemistry (40%), Biochemistry, Genetics and Molecular Biology (35%), Medicine (8%).

Physical Sciences: 11 works · 39.7% of their workChemistry: 11 works · 39.7% of their workOrganic Chemistry: 11 works · 38.1% of their workInorganic Chemistry: 0 works · 1.6% of their workLife Sciences: 10 works · 36.5% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 34.9% of their workMolecular Biology: 10 works · 34.9% of their workPharmacology, Toxicology and Pharmaceutics: 0 works · 1.6% of their workPharmaceutical Science: 0 works · 1.6% of their workEverything else: 4 works · 15.8% of their workHealth Sciences: 2 works · 8.0% of their workMedicine: 2 works · 8.0% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 4.8% of their workOncology: 1 works · 3.2% of their workTHEIR WORKAaron R. Kunzer28works
Life Sciences36%Physical Sciences40%Health Sciences8%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Chemistry1139.7%
    1. Biochemistry, Genetics and Molecular Biology1034.9%
    2. Pharmacology, Toxicology and Pharmaceutics01.6%
  3. Everything else415.8%
    1. Medicine28.0%
  1. 1Organic Chemistry38% of their works
  2. 2Molecular Biology35% of their works
  3. 3Radiology, Nuclear Medicine and Imaging5% of their works
  4. 4Oncology3% of their works
  5. 5Inorganic Chemistry2% of their works
  6. 6Pharmaceutical Science2% of their works

Research topics

Which keywords describe Aaron R. Kunzer's research?

The keywords of their largest research topics: Cancer Therapy, Apoptosis, Cell Death, Acidity Scales, Drug Discovery, Enantioselective Reactions, Nucleophilicity and Organocatalysis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Cancer Therapy92 topics
  2. Apoptosis61 topic
  3. Cell Death61 topic
  4. Acidity Scales41 topic
  5. Drug Discovery41 topic
  6. Enantioselective Reactions41 topic
  7. Nucleophilicity41 topic
  8. Organocatalysis41 topic
  9. Peptide Synthesis41 topic
  10. Fc Receptors31 topic
  11. Proteasome31 topic
  12. RNA Interference31 topic
  13. Therapeutic Antibodies31 topic
  14. Ubiquitin31 topic
  15. siRNA Delivery31 topic
  16. DNA21 topic
  17. Topoisomerases21 topic

Where does Aaron R. Kunzer work?

Aaron R. Kunzer's main affiliation in the publication record is Abbott Fund, United States.

How many publications and citations does Aaron R. Kunzer have?

OpenAlex counts 28 works and 4,822 citations for Aaron R. Kunzer, an h-index of 15, ranking #1,079,341 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Aaron R. Kunzer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.